Skip to content
Screener

Arbutus Biopharma Corporation ABUS Common Stock Shares Issued

Common Stock Shares Issued at other companies

Gilead Sciences logo
Gilead SciencesGILD
1.2B-0.1%
ALN
Alnylam PharmaceuticalsALNY
133.7M+2.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
52.9M+388%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
169.2M+21.8%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
306.5M+3.6%
Prime Medicine logo
Prime MedicinePRME
180.7M+34.4%

Other financials

Income statement

See full
Revenue$1.0M-90.6%
Operating income-$6.0M-501%
Net income-$5.1M-304%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$19.2M-48.8%
Total debt$514.0K-52.8%
Total equity$258.7M+212%
Total assets$274.0M+165%

Cash flow

See full
Operating cash flow-$6.0M+61.8%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation

See full
Market cap$906.7M+41.2%
Enterprise value$888.04M+46.6%
P/E5.9×
P/S-36.7×

Profitability

See full
Operating margin82%+44.9pp
Net margin84.2%+46.6pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity89.6%+65.3pp
Debt / equity0.0×
Current ratio81.4×+60.9×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Arbutus Biopharma Corporation’s 10-Q, filed August 12, 2026.

Filed
Aug 12, 2026, 7:31 AM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q3 2026
Accession
0001447028-26-000045
Line itemJune 30, 2026December 31, 2025
Stockholders’ equity
Common shares
Authorized: Unlimited number without par value
Issued and outstanding: 197,634,118(December 31, 2025: 192,531,225)1,448,1771,421,429
Additional paid-in capital74,32183,318
Deficit(1,215,521)(1,380,073)
Accumulated other comprehensive loss(48,244)(48,098)
Total stockholders’ equity258,73376,576

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Arbutus Biopharma Corporation's common stock shares issued?
Arbutus Biopharma Corporation (ABUS) reported common stock shares issued of 197.6M in Q2 2026.
How has Arbutus Biopharma Corporation's common stock shares issued changed year-over-year?
Arbutus Biopharma Corporation's common stock shares issued increased by 3.1% year-over-year, from 191.6M to 197.6M.
What is the long-term trend for Arbutus Biopharma Corporation's common stock shares issued?
Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's common stock shares issued has grown at a 16.5% compound annual growth rate (CAGR), from 89.7M to 192.5M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Arbutus Biopharma Corporation's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude